← Back to Search

Behavioural Intervention

Asthma Link for Childhood Asthma

N/A
Recruiting
Led By Michelle Trivedi, MD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months
Awards & highlights

Study Summary

This trial aims to find out if a program called Asthma Link, supervised by schools, is better at improving asthma symptoms in children aged 5-14 with poorly controlled asthma compared to just using an

Who is the study for?
This trial is for children aged 5-14 with poorly controlled asthma. It's designed to see if a school program called Asthma Link can help manage their symptoms better than an educational workbook.Check my eligibility
What is being tested?
The study is testing the effectiveness of 'Asthma Link', which involves supervised asthma therapy at school, against just using an educational workbook on asthma care. Children will be randomly placed in one of these two groups.See study design
What are the potential side effects?
Since specific side effects are not listed for this intervention, they may vary depending on individual reactions to the Asthma Link program or any medications used within it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improving Asthma Symptoms
Secondary outcome measures
Improving Healthcare Utilization
Improving Medication Adherence
Improving Quality of Life
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Asthma LinkExperimental Treatment1 Intervention
Practices in the Asthma Link condition will receive brief training on how to identify, refer and arrange for children with poorly controlled asthma to receive school-supervised therapy with the child's school health staff. Participants will receive an educational asthma workbook.
Group II: Enhanced Usual CareActive Control1 Intervention
Practices in the Enhanced Usual Care condition will receive brief training on how to identify and refer the same group of children with poorly controlled asthma and these children will receive an educational asthma workbook.

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
345 Previous Clinical Trials
989,097 Total Patients Enrolled
1 Trials studying Childhood Asthma
66 Patients Enrolled for Childhood Asthma
National Institutes of Health (NIH)NIH
2,714 Previous Clinical Trials
7,510,983 Total Patients Enrolled
1 Trials studying Childhood Asthma
627 Patients Enrolled for Childhood Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,176 Total Patients Enrolled
6 Trials studying Childhood Asthma
2,086 Patients Enrolled for Childhood Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals able to enroll in this study at the moment?

"As per clinicaltrials.gov, this research study is currently in the process of actively pursuing potential participants. The trial was initially listed on 4/4/2024 and most recently revised on 4/23/2024."

Answered by AI

What is the upper limit of participants engaging in this research endeavor?

"Indeed, information on clinicaltrials.gov indicates that this investigation is currently seeking eligible individuals. The trial was first listed on April 4th, 2024, and the latest update occurred on April 23rd, 2024. This study aims to enroll a total of 350 participants from one designated site."

Answered by AI

Is the study open to individuals older than 85 years of age?

"As per the trial's eligibility criteria, individuals aged between 5 and 14 years are eligible to participate."

Answered by AI
~233 spots leftby Jan 2028